The arterial blood supply to the canine AV (atrioventricular) node mainly through the posterior septal artery has been confirmed by LUMB et al.1) and later by JAMES2), while a considerable part of the interventricular septum is supplied by the anterior septal artery.WEST at al.8 described a technique for the catheterization of individual branches of the coronary artery in intact dogs which permits the intra-coronary injection of pharmacological agents.They demonstrated nodal tachycardia from an injection of norepinephrine into the left circumflex artery.NADEAU and AMIR-JAHED4) cannulated the posterior septal artery in order to perfuse the myocardium including the AV node with the animal's own blood led from the femoral artery. They obtained AV block by the selective administration of acetylcholine. In a previous report, the authors5) described an arrangement for perfusion of the sinus node artery at a constant pressure.In the present study the sinus node artery and the posterior septal artery (AV node artery) were simultaneously cannulated and both perfused at a constant pressure of 100 mm Hg.The authors6) reported briefly a new finding, that of AV node activity in blocking acetylcholine-induced fibrillation when nodal tachycardia was induced by the selective administration of norepinephrine into the AV node artery.In this paper the mode of the blocking effect when the pacemaker was shifted to the AV node is analyzed in detail.
METHODS
Twenty mongrel dogs, of both sexes, weighing 6.5 to 18 kg were used.Animals were anesthetized with intravenous sodium pentobarbital, 30 mg/kg.A tracheal tube was inserted and artificial respiration with air was performed by use of a Bird respirator (model 8).The chest was opened in the right fifth intercostal space.The heart was suspended in the pericardial cradle.Both the sinus-and AV node arteries were directly perfused under constant pressure at 100 mm Hg as shown in FIG.1.
Both vagi were cut but the sympathetic nerves left untouched. The dorsal right atrial artery was isolated as already describee.
The AV node artery (the posterior septal artery) was carefully isolated from its origin beneath the terminal portion of the coronary sinus.
Polyethylene tubes were tapered to fit these arteries, tips of which were usually 0.5 to 1.0 mm o. d. Sodium heparin, 500 U/kg, was given intravenously at the beginning of perfusion and 200 U/kg added at one hour intervals.
First, the AV node artery, and then the sinus node artery were cannulated.
The arterial blood led from the femoral artery was driven by a Sigma motor pump to those cannulae. Rubber tubes were connected to these cannulae for the purpose of injecting the drug solutions in each route.
A channel for shunting the excess blood to the femoral vein through the pneumatic resistance of 100 mm Hg was arranged in parallel with the perfusion system. Blood flow to both arteries was measured by electromagnetic flowmeters (Nihon Kohden MF-2). Two electromanometers (Nihon Kohden RP-2) were arranged to measure the perfusion pressure and the systemic arterial pressure.
The ECG (lead II and right auricular lead) was recorded on an electrocardiograph (Nihon Kohden ME-20-TR).
The atrial and ventricular rates were continuously recorded by use of cardiotachographs (Nihon Kohden RP-2), which were triggered by the P wave of the right auricular lead and by the R wave of lead II respectively. The drugs used in these experi ments were acetylcholine chloride (Daiichi) , atropine sulfate, dl-norepinephrine hydrochloride (Sankyo), propranolol (Sumitomo Chemicals) , alprenolol (H 56/28, 1-(o-allylphenoxy)-3-isopropylamino-2-propanol) (Hassle) and carbachol chloride (Chemwey).
The volume of drug solution injected was 0.01 ml which was given in a period of 4 seconds through a 27 gauge needle by a micrometerdrive syringe . Two " AGLA "
(Burroughs Wellcome Co., England) and six "Jintan"( Jintan Terumo. Co., Japan) microsyringes were used. Each drug solution was injected by means of its own microsyringe in order to avoid contamination. The continuous infusion of drug solutions was performed using an infusion-withdrawal pump (Harvard Apparatus Model 600-900) . 2) Prevention of onset of acetylcholine-induced atrial fibrillation by the injection of norepinephrine into the AV node artery (FIGS. 5 and 6) The authors9) reported that increasing doses of acetylcholine given into the sinus node artery induced prominent depression of the sinus rhythm with sudden appearance of atrial fibrillation, the duration of which was usually about 30 sec., and that a given dose of acetylcholine caused atrial fibrillation repetitively in the same animal as shown in the cardiotachogram of FIG. 5. b.
When norepinephrine was injected into the AV node artery simultaneously with the administration of acetylcholine into the sinus node artery, the sinus rhythm was depressed and eventually the pacemaker shifted to the AV node but neither AV nodal tachycardia nor atrial fibrillation was induced (FIG. 5c) . When nodal tachycardia was induced by administration of norepinephrine into the AV node artery , it was depressed by acetylcholine given into the sinus node artery but atrial fibrillation was prevented (FIG . 5d) 5) Blocking of sustained atrial fibrillation by administration of norepinephrine into the AV node artery (FIG. 9) Sustained atrial fibrillation was produced either by infusion of a small dose of acetylcholine or by the injection of carbachol into the sinus node artery10).
In two out of five animals, it was blocked by the administration of norepinephrine into the AV node artery.
When the atrial fibrillation was blocked, AV nodal rhythm appeared.
As soon as the effects of norepinephrine were over, sinus bradycardia took its place and the initial heart rate was resumed when the infusion of acetylcholine were interrupted, as shown in FIG. 9 . The results were similar in sustained atrial fibrillation induced by carbachol6). When acetylcholine-induced fibrillation was not blocked in other three cases, atrial fibrillation continued and AV nodal tachycardia did not occur even by injection of norepinephrine into the AV node artery. 
